Data study
The Peptide Price Index: 2026 Market Report
What research peptides actually cost, per milligram, across the open vendor market — and how far the price for the same compound varies between sellers. Every figure below is computed from live vendor pricing; the full dataset is free to download and cite.
Across the 50 indexed compounds, the premium (75th-percentile) price per mg runs about 1.6× the budget (25th-percentile) price for the typical peptide — and up to 3.5× for the most dispersed.
Key findings
Cheapest per mg
Lowest-cost compounds
- Glutathione$0.0410v
- NAD+$0.1419v
- GHK-Cu$0.7052v
- Cerebrolysin$0.839v
- AICAR$1.1215v
Most expensive per mg
Highest-cost compounds
- ACE-031$119.008v
- Follistatin 344$102.6712v
- IGF-1$54.338v
- Foxo4-DRI$22.0017v
- PEG-MGF$19.5016v
Widest vendor spread
Same compound, biggest price gap
- 5-Amino-1MQ3.5×$1.36–$4.76
- Glutathione2.6×$0.03–$0.09
- IGF-12.5×$29.30–$73.44
- Foxo4-DRI2.4×$10.23–$24.50
- MOTS-c2.3×$3.03–$6.96
In the spotlight
GLP-1 & notable compounds
| Peptide | Median $/mg | Range | Vendors |
|---|---|---|---|
| Semaglutide | $8.93 | $7.70–$10.72 | 10 |
| Retatrutide | $9.14 | $8.50–$11.45 | 12 |
| Cagrilintide | $10.00 | $7.98–$14.55 | 23 |
The full price index
Every compound in the index — median $/mg, the budget-to-premium range, and vendor count. Sort any column or search a compound; every row links to its live vendor-price breakdown. This is the reference table — cite or link the row you need.
| Peptide | |
|---|---|
| Glutathione | $0.04 |
| NAD+ | $0.14 |
| GHK-Cu | $0.70 |
| Cerebrolysin | $0.83 |
| AICAR | $1.12 |
| 5-Amino-1MQ | $2.40 |
| Vesugen | $2.75 |
| Cartalax | $2.87 |
| Testagen | $2.87 |
| Vilon | $2.88 |
| Ovagen | $2.88 |
| Chonluten | $2.95 |
| Livagen | $3.00 |
| SNAP-8 | $3.30 |
| Epithalon | $3.50 |
| Pinealon | $3.50 |
| GHRP-2 | $3.90 |
| Melanotan II | $4.00 |
| PT-141 | $4.05 |
| Semax | $4.37 |
| Thymalin | $4.56 |
| GHRP-6 | $4.60 |
| Selank | $4.60 |
| MOTS-c | $4.92 |
| ARA-290 | $4.95 |
| SS-31 | $5.00 |
| BPC-157 | $5.17 |
| Kisspeptin-10 | $5.85 |
| Ipamorelin | $6.48 |
| DSIP | $6.48 |
| Oxytocin | $7.00 |
| TB-500 | $7.20 |
| Thymosin Alpha-1 | $7.71 |
| Tesamorelin | $7.78 |
| Sermorelin | $8.00 |
| CJC-1295 (without DAC) | $8.20 |
| Gonadorelin | $8.45 |
| Semaglutide | $8.93 |
| AOD-9604 | $9.00 |
| Retatrutide | $9.14 |
| Hexarelin | $9.46 |
| Cagrilintide | $10.00 |
| CJC-1295 DAC | $10.63 |
| LL-37 | $11.80 |
| Humanin | $11.84 |
| PEG-MGF | $19.50 |
| Foxo4-DRI | $22.00 |
| IGF-1 | $54.33 |
| Follistatin 344 | $102.67 |
| ACE-031 | $119.00 |
Research vendor prices only — clinical program costs are not included. A median is shown only where at least 5 vendors and a real price spread exist; thinner data shows the observed range and a limited-sample marker. Contact providers directly for current rates.
Regulatory status of tracked compounds
FDA status of each indexed compound, weighted by vendor-listing volume so the picture reflects market size, not a bare count of compounds. Shown for information only — not an assessment of safety, legality, or suitability of any use.
- Not evaluated by FDA313 listings
- Nomination withdrawn308 listings
- Advisory Vote: Favorable236 listings
- FDA-approved as a drug179 listings
- Banned from compounding128 listings
- Investigational only101 listings
- Advisory Vote: Unfavorable48 listings
- Status not on file27 listings
- Evaluated, not recommended19 listings
of tracked vendor listings are for peptides the FDA has banned from compounding or whose compounding nomination was withdrawn. Only 6 of 50 tracked compounds are FDA-approved as a drug. Status is shown for information only.
Methodology
Sample. 1,359 vendor price points across 50 peptides. A peptide is included only when it clears the published minimum number of distinct active vendors (8), each carrying qualifying, milligram-denominated pricing — so every benchmark reflects a real market, not one seller.
Normalization. Each listing is converted to a USD price per milligram; products without a stated mg weight are excluded. Values are winsorized at the 5th/95th percentile within each peptide, then the p25 / median / p75 are computed in SQL. Figures are direct aggregates — no application-layer rounding beyond four decimals.
Source & cadence. Prices are scraped from public vendor listings by the PeptideBase pipeline and refreshed weekly; this report reflects the live index as of August 26, 2026.
Independence. Ranking in this report: 0 paid placements.
PeptideBase takes no payment for inclusion in this report.
PeptideBase takes no affiliate commission on these vendors.
Inclusion and ranking are produced automatically by the pipeline.
Scope. Research-use vendor pricing only. These compounds are sold for research purposes and are not intended for human use; clinical program pricing (telehealth, compounding pharmacy) follows a different model and is not captured here. See the full methodology and the cost-of-therapy guide.
Writing about a specific compound?
Drop a live, always-current price card into your own page — it pulls the same figures as this index and updates automatically. Works for any tracked compound.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). The Peptide Price Index — 2026 Market Report. Retrieved August 26, 2026, from https://peptidebase.io/price-index/report